NeuroMetrix, Inc, Low Float, Lands Deal With GlaxoSmithKline

New and innovative product. Quell's proven technology is 5x more powerful on average than other over-the-counter pain relief devices. It is discreet and completely wearable to enable pain relief when your patients need it.

Increased quarterly earnings growth.

Low floater

Resistance at at 3.00 range due to the preferred shares being exercisible at 2.83

Target is 2.50. Nice day trade potential. They just had the biggest trading volume in a very long time, by a long shot.

הערה:

buy here

הערה:

fold, DOW collapsing